VIOL's Scarlet Pro radiofrequency microneedling system has received FDA 510(k) clearance as substantially equivalent (product code GEI, general/plastic surgery). The device joins an increasingly crowded RF microneedling segment dominated by Cutera's Secret Pro, Inmode's Fractora, and Candela's Profound.
Devices & Tech
VIOL Scarlet Pro Wins FDA 510(k) Clearance
South Korean RF microneedling device clears U.S. market as competition intensifies.
1-YEAR MOVE
INMD
▲1.0%
| Ticker | Company | 1-year change |
|---|---|---|
| INMD | InMode Ltd. | +1.0% |
Get the free Inside MedSpa brief by email
The free Inside MedSpa brief · no card · unsubscribe anytime. Privacy.
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
The free Inside MedSpa brief · no card · unsubscribe anytime. Privacy.
VIOL's Scarlet Pro clears FDA as RF microneedling market grows crowded.
Scarlet Pro's clearance matters less for innovation than for market saturation. RF microneedling has become commoditized in the U.S. market—practices choose based on needle depth, temperature profile, and pricing rather than clinical differentiation. VIOL's entry suggests the Korean device makers see margin opportunity in the U.S. channel, likely competing on acquisition cost and rebate programs rather than clinical claims.
Source: original report ↗
Frequently asked questions
What is VIOL Scarlet Pro and does it have FDA approval?
VIOL Scarlet Pro is a South Korean radiofrequency microneedling device that received FDA 510(k) clearance as substantially equivalent (product code GEI). It's now cleared for use in general and plastic surgery applications in the U.S. market.
How does Scarlet Pro compare to other RF microneedling devices?
Scarlet Pro competes in a crowded market alongside Cutera's Secret Pro, Inmode's Fractora, and Candela's Profound. Differentiation in RF microneedling now centers on needle depth, temperature profile, and pricing rather than major clinical innovations.
Why are Korean device makers entering the RF microneedling market now?
VIOL's U.S. entry suggests Korean manufacturers see margin opportunity through lower acquisition costs and rebate programs. The RF microneedling segment has become commoditized, making pricing and channel strategy key competitive factors rather than clinical differentiation.
What product code did VIOL Scarlet Pro receive FDA clearance under?
Scarlet Pro received 510(k) clearance under product code GEI, which covers general and plastic surgery devices. This classification means it was deemed substantially equivalent to existing predicate devices on the market.
Is RF microneedling still considered innovative for medspa practices?
RF microneedling has become commoditized in the U.S. market, with clinical outcomes relatively standardized across devices. Practices now differentiate primarily on acquisition cost, rebate programs, and operational factors rather than breakthrough clinical claims.
Business information, not medical or legal advice. Verify product status at FDA.gov.
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
The free Inside MedSpa brief · no card · unsubscribe anytime. Privacy.